Specifications Synonyms Novel Ly9; CRACC;CD2 subset 1; SLAMF7 Source Human SLAMF7/CRACC/CD319 Protein is expressed from HEK293 with mFc (IgG1) tag at the C-Terminus. It contains Ser23-Met226[Accession | Q9NQ25-1] Molecular Weight The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on SDS-PAGE result. Endotoxin Less than 1EU per μg by the LAL method. Purity > 95% as determined by SDS-PAGE and HPLC. Activity ELISA Data: Immobilized Human SLAMF7, mFc Tag at 0.2μg/ml (100μl/Well). Dose response curve for Anti-SLAMF7 Antibody, hFc Tag with the EC50 of 11.7ng/ml determined by ELISA. Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. Storage The product should be stored at -25~-15℃ for 1 year from date of receipt. 2-7 days, 2 ~ 8 °C under sterile conditions after reconstitution. 3 -6 months, -85~-65℃ under sterile conditions after reconstitution. Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles. Note 1.Please operate with lab coats and disposable gloves,for your safety. 2.This product is for research use only.
